Publicações

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-Of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison

AuthID
P-018-SWK

Author(s)

Puig, N

Diels, J

van Sanden, S

Mendes, J

Burnett, H

Cichewicz, A

Lee, S

Hernando, T

Schecter, JM

Lendvai, N

[+5]·

Cavo, M

Miguel, JS

Shune, L

Khan, AM

Sidana, S

Leleu, X

Manier, S

Lipe, B

Weisel, K

Martinez-Lopez, J

View all authors

Tipo de Documento

Article in Press

Year published

2025

Publicado

in ADVANCES IN THERAPY, ISSN: 0741-238X

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1007/s12325-025-03205-8

Pubmed: 40354013

SCOPUS: 2-s2.0-105004762784

Wos: WOS:001485542000001

Source Identifiers

ISSN: 0741-238X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Puig, N;	2	Diels, J;	3	van Sanden, S;
4	Mendes, J;	5	Burnett, H;	6	Cichewicz, A;
7	Lee, S;	8	Hernando, T;	9	Schecter, JM;
10	Lendvai, N;	11	Patel, N;	12	Sanchez-Pina, JM;
13	Rocchi, S;	14	Mina, R;	15	Corradini, P;
16	Cavo, M;	17	Miguel, JS;	18	Shune, L;
19	Khan, AM;	20	Sidana, S;	21	Leleu, X;
22	Manier, S;	23	Lipe, B;	24	Weisel, K;
25	Martinez-Lopez, J;

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-Of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-Of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison

Links Úteis

Ajuda